Bluechiip Limited

ASX:BCT ISIN:AU000000BCT7

Bluechiip Ltd ASX BCTBluechiip Ltd (ASX:BCT) understands that every sample - stem cells, blood, eggs, sperm and other biospecimens - is critical, so our objective is to manage each one with optimal quality in the most efficient way. Bluechiip's advanced management solution is the only one that provides sample temperature with ID in cryogenic environments to. Most importantly, this delivers confidence in every sample.

Bluechiip's unique patented technology is a MEMS-based wireless tracking solution that contains no electronics. It represents a generational change from current tracking methods such as labels (hand-written and pre-printed), barcodes (linear and 2D), and Radio Frequency Identification. Bluechiip tags are either embedded or manufactured into storage products such as vials or bags. Each product can be easily identified, and critical information such as sample temperature, is detected by readers and stored in the Bluechiip software. In addition to functioning in extreme temperatures, the Bluechiip(R) Advanced Sample management solution can survive autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting.

Bluechiip's technology has applications in healthcare, including in cryogenic storage facilities (biobanks and biorepositories), pathology, clinical trials and forensics. Other key markets include cold-chain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation.

Bluechiip: Delivering confidence in every sample.

 

 
    
            

View in Other Languages

News

Bluechiip Ltd (ASX:BCT) December 2018 Quarterly Report

🕔1/30/2019 9:43:23 AM 3903

Bluechiip Limited (ASX:BCT) today released its quarterly cash flow report for the period ended 31 December 2018.

Read Full Article

Bluechiip Ltd (ASX:BCT) AGM Presentation

🕔11/26/2018 8:27:26 AM 3487

Bluechiip Ltd (ASX:BCT) provides the Company's AGM Presentation.

Read Full Article

Bluechiip Ltd (ASX:BCT) Open Briefing Interview with MD Andrew McLellan

🕔10/18/2018 2:34:44 PM 3628

Bluechiip Ltd (ASX:BCT) provides Open Briefing interview with MD Andrew McLellan.

Read Full Article

Bluechiip Ltd (ASX:BCT) Quarterly Report

🕔10/18/2018 2:30:24 PM 3390

Bluechiip Limited (ASX:BCT) today released its quarterly cash flow report for the period ended 30 September 2018.

Read Full Article

Bluechiip Ltd (ASX:BCT) Raises $1.95M in Share Purchase Plan

🕔10/3/2018 9:04:47 AM 3729

Bluechiip Limited (ASX:BCT), a leader in the development of sample-tracking technology for harsh environments, is pleased to report the Share Purchase Plan announced on 10 September 2018, closed on Friday 28 September 2018 and raised approximately $1.95 million.

Read Full Article

Bluechiip Ltd (ASX:BCT) Annual Report to Shareholders

🕔9/24/2018 9:58:12 AM 3161

Bluechiip Ltd (ASX:BCT) provides the Company's Annual Report to shareholders.

Read Full Article

Bluechiip Ltd (ASX:BCT) Completes Oversubscribed Placement

🕔9/14/2018 8:53:38 AM 4182

Bluechiip Limited (ASX:BCT), is pleased to confirm that, further to the ASX Release dated 10 September 2018, the Company has completed the share placement (Placement) of ordinary shares that has raised $5.5 million of funding.

Read Full Article

Bluechiip Ltd (ASX:BCT) Raises $5.5M and Announces Share Purchase Plan

🕔9/10/2018 9:59:52 AM 4489

Bluechiip Limited (ASX:BCT), a leader in the development of sample-tracking technology for harsh environments, today announced it has successfully raised $5.5 million via an oversubscribed placement to sophisticated and professional investors.

Read Full Article

Bluechiip Ltd (ASX:BCT) Open Briefing Interview with MD Andrew McLellan

🕔8/31/2018 9:44:42 AM 3954

Bluechiip Ltd (ASX:BCT) provides the record of Open Briefing interview with MD Andrew McLellan.

Read Full Article

Bluechiip Ltd (ASX:BCT) Signs Three-Year A$15.9M Supply Deal with Labcon

🕔8/29/2018 9:56:34 AM 4370

Bluechiip Limited (ASX:BCT) a leader in the development of sample-tracking technology for harsh environments, today announced the signing of a three-year $US11.6 million ($A15.9 million) deal to supply its chips and associated hardware and services to vial manufacturer Labcon North America.

Read Full Article
###

113,343 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 203) (Last 30 Days: 799) (Since Published: 73201) 

Company Data

    Headquarters
  • 1 Dalmore Drive
    Caribbean Business Park
    Scoresby VIC 3179 AUSTRALIA
  • Telephone
  • +61-3-9763-9763 
  • Fax
  • +61-3-9763-9764 
  • Principal Sector
  • Infrastructure & Technology 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.bluechiip.com

Company Reports

More News Results

  • 2024/07/10: BCT expansion order from Global Pharma client and Update*
  • 2024/07/05: Change of Company Secretary*
  • 2024/06/19: Change in substantial holding*
  • 2024/06/17: Cleansing Notice*
  • 2024/06/17: Application for quotation of securities - BCT*
  • 2024/06/12: Company Update*
  • 2024/06/12: Proposed issue of securities - BCT*
  • 2024/06/12: Proposed issue of securities - BCT*
  • 2024/06/12: Bluechiip completes placement*
  • 2024/06/07: Trading halt*
*refer to company website

Presentations

Download Presentation

Research Report

Download Presentation

Quarterly Report

Download Presentation

Social Media